Kristica Kolyouthapong

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Thromboembolic (TE) events and hemorrhagic complications continue to remain as frequent adverse events and causes of death after mechanical circulatory support device (MCSD) implantation. To counterbalance this postimplant multifactorial hypercoagulable state, antithrombotic therapy given postimplant must be individually tailored to keep patient adequately(More)
  • 1